News Daily News Another DOAC Fails in the Setting of Mechanical Heart Valves Todd Neale September 28, 2022
News Conference News TCT 2022 As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant Michael O'Riordan September 18, 2022
News Daily News Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials Michael O'Riordan March 23, 2022
News Features Aortic Valve Replacement: What’s on the Wish List for Future Devices? Shelley Wood March 14, 2022
News Daily News Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data Caitlin E. Cox August 21, 2019
News Daily News New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI Shelley Wood February 19, 2019
News Conference News The Structural Heart Disease Summit 2018 SAFE-MANTA: Large-Bore Vascular Closure Device Achieves Fast Hemostasis With Few Complications Michael O'Riordan June 23, 2018
News Conference News PCR London Valves 2016 Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance Shelley Wood September 22, 2016
News Conference News EuroPCR 2016 EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’ Shelley Wood May 16, 2016
News Conference News SCAI 2016 Gender and TAVR: Studies Highlight Different Outcomes Between Men and Women L.A. McKeown May 11, 2016
News Conference News ACC 2016 Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes Michael O'Riordan April 07, 2016
News Industry News Similar Results With Bivalirudin Compared With Heparin Anticoagulation In TAVR Patients October 15, 2015
News Conference News TCT 2015 BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR Yael L. Maxwell October 15, 2015
News Daily News JAMA Viewpoint: TAVR Promise Must Be Weighed Against Risks, Limitations Yael L. Maxwell August 09, 2012